Intraprocedural Assessment of Ablation Margins Using Computed Tomography Co-registration in Primary Liver Tumor Treatment With Percutaneous Ablation

Inclusion Criteria: * Age 18 yrs or above * HCC very early (0) or early stage (A) according to the BCLC staging system * Either de novo or recurrent HCC (prior locoregional therapy is allowed in the study) * Candidate for percutaneous thermal ablation as discussed in a multidisciplinary tumor board. Ablation as 'bridge-to-transplant' is allowed in the study Exclusion Criteria: * Estimated GFR \<30 ml/min * Morbid obesitas or any pulmonary condition that is a contraindication to prolonged apnea and high jet-ventilation * Child Pugh C * Portal vein tumor invasion * Extrahepatic metastasis * Uncorrectable coagulopathy * Any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule * Inability or unwillingness to give informed consent